Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacomicrobiomics: Exploiting the Drug-Microbiota Interactions in Antihypertensive Treatment
Huiqing Chen, Jinyu Gong, Kai Xing, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Drug-microbiota interactions: an emerging priority for precision medicine
Qing Zhao, Yao Chen, Weihua Huang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 83
Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome
Brian Bicknell, Ann Liebert, Thomas J. Borody, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9577-9577
Open Access | Times Cited: 68
Mechanisms and Clinical Implications of Human Gut Microbiota-Drug Interactions in the Precision Medicine Era
Shuaiqi Wang, Dianwen Ju, Xian Zeng
Biomedicines (2024) Vol. 12, Iss. 1, pp. 194-194
Open Access | Times Cited: 16
Harmony Within: Unravelling the Microbiome–Immune System Symbiosis for Health
Anuupama Suchiita, Neelu Gupta, Kajal Nandi, et al.
Advanced Gut & Microbiome Research (2025) Vol. 2025, Iss. 1
Open Access | Times Cited: 2
Effects of intestinal flora on pharmacokinetics and pharmacodynamics of drugs
Amina Džidić-Krivić, Jasna Kusturica, Emina Karahmet Sher, et al.
Drug Metabolism Reviews (2023) Vol. 55, Iss. 1-2, pp. 126-139
Open Access | Times Cited: 27
Gut microbiota dependant trimethylamine N-oxide and hypertension
Katongo Hope Mutengo, Sepiso K. Masenga, Aggrey Mweemba, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 23
Targeting the gut microbiome to control drug pharmacomicrobiomics: the next frontier in oral drug delivery
Srinivas Kamath, Andrea M. Stringer, Clive A. Prestidge, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 10, pp. 1315-1331
Closed Access | Times Cited: 20
Prospects for Leveraging the Microbiota as Medicine for Hypertension
David J. Durgan, Jasenka Zubcevic, Matam Vijay–Kumar, et al.
Hypertension (2024) Vol. 81, Iss. 5, pp. 951-963
Open Access | Times Cited: 7
The potential impact of a probiotic: Akkermansia muciniphila in the regulation of blood pressure—the current facts and evidence
Arun Prasath Lakshmanan, Selvasankar Murugesan, Souhaila Al Khodor, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 28
The Interplay between Gut Microbiota and Oral Medications and Its Impact on Advancing Precision Medicine
Sara Mousa, Muhammad Sarfraz, Walaa K. Mousa
Metabolites (2023) Vol. 13, Iss. 5, pp. 674-674
Open Access | Times Cited: 14
System Overview from Physiological and Pathological Standpoints
Gustavo Rodrigues Pedrino, Luíza Toubas Chaul, Virgínia Farias Alves, et al.
(2025), pp. 1-34
Closed Access
The Bidirectional Relationship Between Cardiovascular Medications and Oral and Gut Microbiome Health: A Comprehensive Review
Gangani Dharmarathne, Samia Kazi, Shalinie King, et al.
Microorganisms (2024) Vol. 12, Iss. 11, pp. 2246-2246
Open Access | Times Cited: 3
The gut microbiome as a modulator of arterial function and age-related arterial dysfunction
Abigail G. Longtine, Nathan Greenberg, Yara Bernaldo de Quirós, et al.
AJP Heart and Circulatory Physiology (2024) Vol. 326, Iss. 4, pp. H986-H1005
Closed Access | Times Cited: 2
Microbial influence on blood pressure: unraveling the complex relationship for health insights
Alexander Machado Cardoso
Microbiome Research Reports (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 2
Drug and gut microbe relationships: Moving beyond antibiotics
Shreyas V. Kumbhare, Inti Pedroso, Juan A. Ugalde, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 11, pp. 103797-103797
Closed Access | Times Cited: 5
Association of enterolactone with blood pressure and hypertension risk in NHANES
Cynthia M. Weiner, Shannon E. Khan, Caleb Leong, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0302254-e0302254
Open Access | Times Cited: 1
Gut microbiome and inflammation in cardiovascular drug response: trends in therapeutic success and commercial focus
Firoz Anwar, Fahad A. Al‐Abbasi, Omar A. Al-Bar, et al.
Inflammopharmacology (2024)
Closed Access | Times Cited: 1
How Hydroxyurea Alters the Gut Microbiome: A Longitudinal Study Involving Angolan Children with Sickle Cell Anemia
Mariana Delgadinho, Catarina Ginete, Brígida Santos, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9061-9061
Open Access | Times Cited: 6
An Update on Drug–Nutrient Interactions and Dental Decay in Older Adults
Victoria Bell, Ana Rita Rodrigues, Μαρία Αντωνιάδου, et al.
Nutrients (2023) Vol. 15, Iss. 23, pp. 4900-4900
Open Access | Times Cited: 3
Oral antibiotics perturbation on gut microbiota after prostate biopsy
Joseph Kai Man Li, Lin Wang, Becky Su Yan Lau, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 5
Interaction of drugs with gut microbiota modulators
Dong‐Hyun Kim
Drug Metabolism Reviews (2023) Vol. 55, Iss. 3, pp. 181-194
Closed Access | Times Cited: 2
Effect of Gut Microbiota on the Pharmacokinetics of Nifedipine in Spontaneously Hypertensive Rats
Rong Zhou, Haijun Yang, Peng Zhu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2085-2085
Open Access | Times Cited: 2
Impact of Repeated Infantile Exposure to Surgery and Anesthesia on Gut Microbiota and Anxiety Behaviors at Age 6–9
Xiaoyu Yang, Yan Wu, Xuanxian Xu, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 5, pp. 823-823
Open Access | Times Cited: 2
Targeting the Filipino gut microbiota in the management of hypertension
Abraham C. Sianoya, Nemencio A. Nicodemus, Leslie Michelle M. Dalmacio
The Egyptian Heart Journal (2024) Vol. 76, Iss. 1
Open Access
Effect of Motion Sickness Drugs [Cinnarizine, Dimenhydrinate, Promethazine] on Gut Bacteria [E. coli]
R. Subashini, Mesta Shreya, Srivibha Parthasarathy, et al.
(2024), pp. 1-4
Closed Access
Page 1 - Next Page

Scroll to top